Last reviewed · How we verify
NCT05213130
Blood Donation and Subjective Well-being
NA trial testing Information in Blood Donation in 601 participants. Completed in 16 March 2022.
12 March 2022
Quick facts
| Lead sponsor | Guangzhou Blood Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 601 |
| Start date | 18 January 2022 |
| Primary completion | 12 March 2022 |
| Estimated completion | 16 March 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Information
Conditions studied
- Blood Donation — all drugs for Blood Donation →
- Happiness — all drugs for Happiness →
Sponsor
Guangzhou Blood Center — full company profile →
Who can join
Adults 18 to 60, any sex, with Blood Donation or Happiness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the psychological effects of blood donation among adult donors at the Guangzhou Blood Center. The primary objective is to examine whether a brief gratitude-based intervention delivered after donation enhances donors' subjective well-being (SWB) and basic psychological need (BPN) satisfaction. Participants who complete a whole-blood donation are randomly assigned to either an Intervention group, receiving a standardized gratitude reinforcement message accompanied by a vignette emphasizing the life-saving impact of donation, or a Control group that receives no additional message. All participants complete questionnaires at Time 1 (immediately after donation) and at Time 2 (4-22 days later), assessing SWB and related psychosocial variables.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Blood donation and subjective wellbeing: a cross-sectional survey and a randomized trial.
Ou-Yang J, Feng FF, Ke RR, Huang XY, et al · · 2026 · PMID 41969898 · DOI 10.3389/fpsyg.2026.1795243
Verify or expand the search:
- PubMed search for NCT05213130
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Information
Trials testing the same drug.
- NCT07489053 — Optimizing Functional Recovery After Breast Cancer Treatment · NA · not yet recruiting
- NCT07220681 — Integrated Health Care for PTSD · NA · not yet recruiting
- NCT06723600 — Effect of Informing Family Members of Patients During Surgery · NA · recruiting
- NCT06585956 — Prevent Post-discharge Hospital Admissions Using Mobile Phone App · completed
- NCT04224727 — The Impact of Group Commitment Contracts on Smoking Cessation and Weight Loss · NA · suspended
Other recruiting trials for Blood Donation
Currently open trials in the same condition.
- NCT06138899 — Enhancing Blood Donation at Schools and Beyond in Malawi · NA · active not recruiting
- NCT05678647 — Sucrosomial Iron and Iron Sulphate to Blood Donors · NA · active not recruiting
Other Guangzhou Blood Center trials
Trials by the same sponsor.
- NCT05319951 — Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation · NA · completed
- NCT04484896 — Message Framing on Recruiting Rh-D Negative Blood Donors · NA · unknown
- NCT04431180 — Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# · NA · unknown
- NCT04410458 — Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） · NA · unknown
- NCT04370886 — Recruit Blood Donors Via SMS During Epidemic of COVID-19 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05213130 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Blood Center
- Last refreshed: 13 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05213130.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing